Basic Information
Basic information for LINC02614-212-21aa
Peptide Name LINC02614-212-21aa
Genome Position chr3:125848339-125848401[-]
Species Human
Peptide Sequence MRYLALTPSPARRSRLGVSTS
Peptide Length 21
Unique No (LINC02614-217-21aa,LINC02614-223-21aa,LINC02614-224-21aa)
Grand Average of Hydropathicity -0.3048
Relative Molecular Mass 2680.05
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000241288;LINC02614
Transcript ID/Name ENST00000614362;LINC02614-212
Transcript Length 540
Coding Ability 0.4852
DNA Sequence Corresponding to Peptide ATGAGGTACCTGGCCTTGACGCCCTCCCCGGCTAGACGGTCCAGATTGGGGGTGTCCACATCC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :